Diagnostic accuracy of procalcitonin in critically ill immunocompromised patients
Open Access
- 24 August 2011
- journal article
- research article
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 11 (1) , 1-8
Abstract
Background: Recognizing infection is crucial in immunocompromised patients with organ dysfunction. Our objective was to assess the diagnostic accuracy of procalcitonin (PCT) in critically ill immunocompromised patients. Methods: This prospective, observational study included patients with suspected sepsis. Patients were classified into one of three diagnostic groups: no infection, bacterial sepsis, and nonbacterial sepsis. Results: We included 119 patients with a median age of 54 years (interquartile range [IQR], 42-68 years). The general severity (SAPSII) and organ dysfunction (LOD) scores on day 1 were 45 (35-62.7) and 4 (2-6), respectively, and overall hospital mortality was 32.8%. Causes of immunodepression were hematological disorders (64 patients, 53.8%), HIV infection (31 patients, 26%), and solid cancers (26 patients, 21.8%). Bacterial sepsis was diagnosed in 58 patients and nonbacterial infections in nine patients (7.6%); 52 patients (43.7%) had no infection. PCT concentrations on the first ICU day were higher in the group with bacterial sepsis (4.42 [1.60-22.14] vs. 0.26 [0.09-1.26] ng/ml in patients without bacterial infection, P < 0.0001). PCT concentrations on day 1 that were > 0.5 ng/ml had 100% sensitivity but only 63% specificity for diagnosing bacterial sepsis. The area under the receiver operating characteristic (ROC) curve was 0.851 (0.78-0.92). In multivariate analyses, PCT concentrations > 0.5 ng/ml on day 1 independently predicted bacterial sepsis (odds ratio, 8.6; 95% confidence interval, 2.53-29.3; P = 0.0006). PCT concentrations were not significantly correlated with hospital mortality. Conclusion: Despite limited specificity in critically ill immunocompromised patients, PCT concentrations may help to rule out bacterial infection.Keywords
This publication has 28 references indexed in Scilit:
- BAL Neutrophils, Serum Procalcitonin, and C-Reactive Protein To Predict Bacterial Infection in the Immunocompromised HostChest, 2007
- Antibiotic Treatment of Exacerbations of COPDChest, 2007
- Evaluation of serum C-reactive protein, procalcitonin, tumor necrosis factor alpha, and interleukin-10 levels as diagnostic and prognostic parameters in patients with community-acquired sepsis, severe sepsis, and septic shockEuropean Journal of Clinical Microbiology & Infectious Diseases, 2006
- Procalcitonin and C-reactive protein levels in HIV-positive subjects with tuberculosis and pneumoniaEuropean Respiratory Journal, 2005
- Potential use of procalcitonin as a diagnostic criterion in febrile neutropenia: experience from a multicentre studyClinical Microbiology and Infection, 2004
- Discrimination of sepsis and systemic inflammatory response syndrome by determination of circulating plasma concentrations of procalcitonin, protein complement 3a, and interleukin-6Critical Care Medicine, 2000
- Calcitonin precursors are reliable markers of sepsis in a medical intensive care unitCritical Care Medicine, 2000
- Prediction of Microbial Infection and Mortality in Medical Patients with Fever: Plasma Procalcitonin, Neutrophilic Elastase‐α‐Antitrypsin, and Lactoferrin Compared with Clinical VariablesClinical Infectious Diseases, 1999
- A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter studyJAMA, 1993
- High serum procalcitonin concentrations in patients with sepsis and infectionThe Lancet, 1993